Pricing Log in Create free account

TScan Therapeutics, Inc. (TCRX) vs Tvardi Therapeutics, Inc. (TVRD)

TScan Therapeutics, Inc. and Tvardi Therapeutics, Inc. are both Biotechnology companies. TScan Therapeutics, Inc. and Tvardi Therapeutics, Inc. are of similar size ($12.3M and $11.5M). TScan Therapeutics, Inc. grew revenue faster over the last twelve months: 2.15% against −55.3%. Tvardi Therapeutics, Inc. has the higher net margin (0.00% vs −1,655.4%) and the higher return on invested capital (0.00% vs −4,588.2%). Across the 18 metrics below, Tvardi Therapeutics, Inc. leads on 10 and TScan Therapeutics, Inc. on 8.

Valuation

Metric TCRX TVRD Biotechnology median
P/E n/m n/m 10.60
P/S 3.29 1.20 9.40
P/B 0.34 1.09 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.37 n/m 0.66
EV/Sales (6.19) 6.98 9.02
Earnings yield (505.56%) (287.63%) (32.88%)
Free cash flow yield (506.23%) (309.54%) (23.13%)

Profitability

Metric TCRX TVRD Biotechnology median
Gross margin 100.00% 146.85% 68.51%
Operating margin (1,695.15%) 0.00% 0.00%
Net margin (1,655.35%) 0.00% 0.00%
Free cash flow margin (1,665.18%) 0.00% 0.00%
Return on equity (95.80%) (126.19%) (51.96%)
Return on assets (50.09%) (85.08%) (46.06%)
Return on invested capital (4,588.23%) 0.00% 0.00%

Growth

Metric TCRX TVRD Biotechnology median
Revenue growth (TTM) 2.15% (55.30%) 6.76%
EPS growth (last fiscal year) 12.28% 71.45% 29.88%
Revenue growth, 5-year CAGR 56.92% (18.53%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric TCRX TVRD Biotechnology median
Debt to equity 0.47 0.00 0.00
Current ratio 3.37 1.87 4.97
Net debt to EBITDA 0.90 1.15 1.01

Dividend

Metric TCRX TVRD Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric TCRX TVRD Biotechnology median
Market cap 12.32m 11.53m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack